Ignite Creation Date:
2024-06-16 @ 11:52 AM
Last Modification Date:
2024-10-26 @ 3:31 PM
Study NCT ID:
NCT06451848
Status:
RECRUITING
Last Update Posted:
2024-06-11
First Post:
2024-05-28
Brief Title:
A Bioequivalence Study of Two Different Dosage Form of Genakumab
Sponsor:
Changchun GeneScience Pharmaceutical Co Ltd
Organization:
Changchun GeneScience Pharmaceutical Co Ltd
Key Dates - Follows AllAPIJSON File Order
Start Date:
2024-06-29
Start Date Type:
ESTIMATED
Primary Completion Date:
2025-01-19
Primary Completion Date Type:
ESTIMATED
Completion Date:
2025-03-31
Completion Date Type:
ESTIMATED
First Submit Date:
2024-05-28
First Submit QC Date:
June 4 2024
Study First Post Date:
2024-06-11
Study First Post Date Type:
ACTUAL
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2024-06-04
Last Update Post Date:
2024-06-11
Last Update Post Date Type:
ACTUAL